Market Exclusive

Analyst Downgrades – PLx Pharma (NASDAQ:PLXP) (NASDAQ:PLXP) Stock Gets Downgraded By Janney Montgomery Scott from Buy to Neutral

Analyst Ratings For PLx Pharma (NASDAQ:PLXP) (NASDAQ:PLXP)

Today, PLx Pharma (NASDAQ:PLXP) (NASDAQ:PLXP) stock was downgraded by Janney Montgomery Scott from Buy to Neutral with a price target of $14.00.

Some recent analyst ratings include

Recent Insider Trading Activity For PLx Pharma (NASDAQ:PLXP) (NASDAQ:PLXP)
PLx Pharma (NASDAQ:PLXP) (NASDAQ:PLXP) has insider ownership of 47.70% and institutional ownership of 25.01%.

Recent Trading Activity for PLx Pharma (NASDAQ:PLXP) (NASDAQ:PLXP)
Shares of PLx Pharma (NASDAQ:PLXP) closed the previous trading session at 4.78 down -0.52 9.72% with 5.550000190734863 shares trading hands.

Exit mobile version